Moderna advances pandemic preparedness agenda with UK clearance for commercial mRNA vaccine plant
Furthering its goal to expand the reach of its mRNA vaccines and prepare for future pandemics, Moderna has received a thumbs up for commercial manufacturing of its shots in the United Kingdom. The site that received the license will work in tandem with facilities in Australia and Canada to crank out vaccines on a global scale in the event of a future health emergency, Moderna said.
Furthering its goal to expand the reach of its mRNA vaccines and prepare for future pandemics, Moderna has received a thumbs up for commercial manufacturing of its shots in the United Kingdom. The site that received the license will work in tandem with facilities in Australia and Canada to crank out vaccines on a global scale in the event of a future health emergency, Moderna said.
